Elypta
Latest round
- Series A
Last raised
- Jun 2022
Total raised
- $28M
Investors
- 7
About Elypta
Founded in 2017 in Solna, Sweden, Elypta AB focuses on developing noninvasive cancer diagnostics. Founded by Francesco Gatto, Elypta has completed 2 deals to date, with the most recent deal occurring on June 20, 2022.Elypta's primary offering is a metabolism-based liquid biopsy aimed at early cancer detection. This innovative approach focuses on measuring the GAGome, a collection of system biomarkers linked to tumor metabolism, analyzed using machine learning algorithms to identify cancer signatures in a noninvasive manner. The service assists healthcare providers in enabling earlier diagnosis and intervention, ultimately aiming to reduce cancer mortality rates. Elypta's solutions are directed towards clinical applications and are positioned to serve hospitals, research institutions, and oncologists across Europe and North America.30 mn for the most recent year 2022. The company generated revenue primarily through partnerships and collaborations with academic institutions and healthcare organizations utilizing its liquid biopsy technology in clinical settings. Transaction structures typically involve agreements where Elypta provides its diagnostic services or products to hospitals and clinics, facilitating early cancer detection.00 mn, to develop and validate blood and urine tests for Multi-Cancer Early Detection (MCED) in adults with no cancer symptoms, as well as for the detection of recurrence in kidney cancer patients. The company aims to expand its market reach, targeting healthcare providers in additional regions across Europe and North America by 2024, further bolstering its role in transforming cancer diagnostics.
Who invested in Elypta
7 investors across 2 rounds
See all investors in Elypta
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Elypta
Who invested in Elypta?
Elypta has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Elypta raised?
Elypta has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Elypta last raise money?
Elypta's most recent round on record is a Series A, in Jun 2022.
What does Elypta do?
Founded in 2017 in Solna, Sweden, Elypta AB focuses on developing noninvasive cancer diagnostics.
Where is Elypta headquartered?
Elypta is headquartered in Solna, Sweden.
Which VCs invest in companies like Elypta?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back medical devices & equipment companies at Elypta's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like Elypta? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.